Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Plos One|October 3, 2013
The human minor histocompatibility antigen 1 is a RhoGAPBart-Jan de Kreuk, Antje Schaefer, Eloise C Anthony, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|September 23, 2003
Quantification of the HA-1 gene product at the RNA level; relevance for immunotherapy of hematological malignanciesMartina Wilke, Harry Dolstra, Frans Maas, et al.
Blood|December 20, 2008
Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapyLothar Hambach, Kam-Wing Ling, Jos Pool, et al.
Diabetes|January 11, 2019
Epitope Stealing as a Mechanism of Dominant Protection by HLA-DQ6 in Type 1 DiabetesMenno van Lummel, David T P Buis, Cherish Ringeling, et al.
Diabetes|January 1, 2016
Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans MoleculeMenno van Lummel, Peter A van Veelen, Arnoud H de Ru, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2016
Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DRMenno van Lummel, Peter A van Veelen, Arnoud H de Ru, et al.
Frontiers in Immunology|May 31, 2024
Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulatorsHaiyu Wang, Fleur S van de Bovenkamp, Douwe J Dijkstra, et al.
Pageof 3